Chugai Pharmaceutical (TYO:4519) reported a 31% increase in net income to 97.2 billion yen for the three months ended March 31, from 74.4 billion yen a year ago.
The pharmaceutical group's earnings per share rose to 59.08 yen from 45.21 yen a year ago, according to a Thursday bourse filing.
Revenue jumped 22% to 288.5 billion yen from 236.9 billion yen a year earlier.
For the year ending Dec. 31, the company expects core net income to increase 3.2% to 410.0 billion yen or 250.00 yen per share, while revenue is projected to rise 1.7% to 1.19 trillion yen.
The company plans to pay interim and year-end dividends of 125.00 yen per share each, including a special dividend for its 100th anniversary, totaling 250.00 yen per share for the fiscal year.
Price (JPY): $8285.00, Change: $+34, Percent Change: +0.41%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。